标题
Levodopa-induced dyskinesia in Parkinson disease: Current and evolving concepts
作者
关键词
-
出版物
ANNALS OF NEUROLOGY
Volume 84, Issue 6, Pages 797-811
出版商
Wiley
发表日期
2018-10-25
DOI
10.1002/ana.25364
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Deep brain stimulation for Parkinson’s disease: meta-analysis of results of randomized trials at varying lengths of follow-up
- (2018) Alireza Mansouri et al. JOURNAL OF NEUROSURGERY
- Long-term adherence to apomorphine infusion in patients with Parkinson disease: a 10-year observational study
- (2017) Thomas E. Kimber et al. INTERNAL MEDICINE JOURNAL
- Chemogenetic stimulation of striatal projection neurons modulates responses to Parkinson’s disease therapy
- (2017) Cristina Alcacer et al. JOURNAL OF CLINICAL INVESTIGATION
- Adaptive deep brain stimulation controls levodopa-induced side effects in Parkinsonian patients
- (2017) Manuela Rosa et al. MOVEMENT DISORDERS
- Trial of dextromethorphan/quinidine to treat levodopa-induced dyskinesia in Parkinson's disease
- (2017) Susan H. Fox et al. MOVEMENT DISORDERS
- Rabphilin 3A: A novel target for the treatment of levodopa-induced dyskinesias
- (2017) Jennifer Stanic et al. NEUROBIOLOGY OF DISEASE
- Teaching Video Neuro Images : The underrecognized diphasic dyskinesia of Parkinson disease
- (2017) Leo Verhagen Metman et al. NEUROLOGY
- Metabotropic glutamate receptors as therapeutic targets in Parkinson's disease: An update from the last 5 years of research
- (2017) Nadhir Litim et al. NEUROPHARMACOLOGY
- Diphasic dyskinesias during levodopa-carbidopa intestinal gel (LCIG) infusion in Parkinson's disease
- (2017) Mario Meloni et al. PARKINSONISM & RELATED DISORDERS
- Common Myths in the Use of Levodopa in Parkinson Disease
- (2017) Alberto J. Espay et al. JAMA Neurology
- ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson Disease (EASE LID Study)
- (2017) Rajesh Pahwa et al. JAMA Neurology
- A Role for Mitogen- and Stress-Activated Kinase 1 in L-DOPA –Induced Dyskinesia and ∆FosB Expression
- (2016) Michael Feyder et al. BIOLOGICAL PSYCHIATRY
- Cortical Control of Striatal Dopamine Transmission via Striatal Cholinergic Interneurons
- (2016) Polina Kosillo et al. CEREBRAL CORTEX
- L-DOPA Oppositely Regulates Synaptic Strength and Spine Morphology in D1 and D2 Striatal Projection Neurons in Dyskinesia
- (2016) Luz M Suarez et al. CEREBRAL CORTEX
- Novel Levodopa Formulations for Parkinson’s Disease
- (2016) Maria Eliza Freitas et al. CNS DRUGS
- Clinical phenotype and risk of levodopa-induced dyskinesia in Parkinson’s disease
- (2016) Alessandra Nicoletti et al. JOURNAL OF NEUROLOGY
- Gamma Oscillations in the Hyperkinetic State Detected with Chronic Human Brain Recordings in Parkinson's Disease
- (2016) Nicole C. Swann et al. JOURNAL OF NEUROSCIENCE
- A Placebo-Controlled Trial of AQW051 in Patients With Moderate to Severe Levodopa-Induced Dyskinesia
- (2016) Claudia Trenkwalder et al. MOVEMENT DISORDERS
- Resting-state connectivity predicts levodopa-induced dyskinesias in Parkinson's disease
- (2016) Damian M. Herz et al. MOVEMENT DISORDERS
- A Phase 2A Trial of the Novel mGluR5-Negative Allosteric Modulator Dipraglurant for Levodopa-Induced Dyskinesia in Parkinson's Disease
- (2016) François Tison et al. MOVEMENT DISORDERS
- Effect of levodopa-carbidopa intestinal gel on dyskinesia in advanced Parkinson's disease patients
- (2016) Angelo Antonini et al. MOVEMENT DISORDERS
- Hyperkinetic disorders and loss of synaptic downscaling
- (2016) Paolo Calabresi et al. NATURE NEUROSCIENCE
- Dramatic differences in susceptibility to l-DOPA-induced dyskinesia between mice that are aged before or after a nigrostriatal dopamine lesion
- (2016) Francesco Bez et al. NEUROBIOLOGY OF DISEASE
- Optogenetic activation of striatal cholinergic interneurons regulates L-dopa-induced dyskinesias
- (2016) Tanuja Bordia et al. NEUROBIOLOGY OF DISEASE
- Serotonin-to-dopamine transporter ratios in Parkinson disease
- (2016) Andreas-Antonios Roussakis et al. NEUROLOGY
- Dual κ-agonist/μ-antagonist opioid receptor modulation reduces levodopa-induced dyskinesia and corrects dysregulated striatal changes in the nonhuman primate model of Parkinson disease
- (2015) Lisa F. Potts et al. ANNALS OF NEUROLOGY
- Abnormal dopaminergic modulation of striato-cortical networks underlies levodopa-induced dyskinesias in humans
- (2015) Damian M. Herz et al. BRAIN
- Loss of phosphodiesterase 10A expression is associated with progression and severity in Parkinson’s disease
- (2015) Flavia Niccolini et al. BRAIN
- Eltoprazine counteracts l-DOPA-induced dyskinesias in Parkinson’s disease: a dose-finding study
- (2015) Per Svenningsson et al. BRAIN
- Cannabinoid-dopamine interactions in the physiology and physiopathology of the basal ganglia
- (2015) Concepción García et al. BRITISH JOURNAL OF PHARMACOLOGY
- Rotigotine is a potent agonist at dopamine D1receptors as well as at dopamine D2and D3receptors
- (2015) Martyn Wood et al. BRITISH JOURNAL OF PHARMACOLOGY
- NLX-112, a novel 5-HT 1A receptor agonist for the treatment of l -DOPA-induced dyskinesia: Behavioral and neurochemical profile in rat
- (2015) H. Iderberg et al. EXPERIMENTAL NEUROLOGY
- Adaptive deep brain stimulation in a freely moving parkinsonian patient
- (2015) Manuela Rosa et al. MOVEMENT DISORDERS
- The motor inhibition system in Parkinson's disease with levodopa-induced dyskinesias
- (2015) Antonio Cerasa et al. MOVEMENT DISORDERS
- The role of pallidal serotonergic function in Parkinson's disease dyskinesias: a positron emission tomography study
- (2015) Ruben Smith et al. NEUROBIOLOGY OF AGING
- Enhanced histamine H2 excitation of striatal cholinergic interneurons in l-DOPA-induced dyskinesia
- (2015) Sean Austin O. Lim et al. NEUROBIOLOGY OF DISEASE
- Putaminal serotonergic innervation
- (2015) Jee-Young Lee et al. NEUROLOGY
- M4 Muscarinic Receptor Signaling Ameliorates Striatal Plasticity Deficits in Models of L-DOPA-Induced Dyskinesia
- (2015) Weixing Shen et al. NEURON
- Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease
- (2015) Matthieu F. Bastide et al. PROGRESS IN NEUROBIOLOGY
- NMDA receptor GluN2A/GluN2B subunit ratio as synaptic trait of levodopa-induced dyskinesias: from experimental models to patients
- (2015) Manuela Mellone et al. Frontiers in Cellular Neuroscience
- The acute brain response to levodopa heralds dyskinesias in Parkinson disease
- (2014) Damian M. Herz et al. ANNALS OF NEUROLOGY
- A network centred on the inferior frontal cortex is critically involved in levodopa-induced dyskinesias
- (2014) Antonio Cerasa et al. BRAIN
- The modern pre-levodopa era of Parkinson's disease: insights into motor complications from sub-Saharan Africa
- (2014) R. Cilia et al. BRAIN
- Detection of cannabinoid receptors CB1 and CB2 within basal ganglia output neurons in macaques: changes following experimental parkinsonism
- (2014) Salvador Sierra et al. Brain Structure & Function
- Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson’s disease patients
- (2014) Marios Politis et al. JOURNAL OF CLINICAL INVESTIGATION
- Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): a large, open-label, pragmatic randomised trial
- (2014) PD MED Collaborative Group LANCET
- The mGluR5 negative allosteric modulator dipraglurant reduces dyskinesia in the MPTP macaque model
- (2014) Erwan Bezard et al. MOVEMENT DISORDERS
- Direct and indirect pathways of basal ganglia: a critical reappraisal
- (2014) Paolo Calabresi et al. NATURE NEUROSCIENCE
- Lack of depotentiation at basal ganglia output neurons in PD patients with levodopa-induced dyskinesia
- (2014) I.A. Prescott et al. NEUROBIOLOGY OF DISEASE
- Selective loss of bi-directional synaptic plasticity in the direct and indirect striatal output pathways accompanies generation of parkinsonism and l-DOPA induced dyskinesia in mouse models
- (2014) Sherri L. Thiele et al. NEUROBIOLOGY OF DISEASE
- Cell type-specific plasticity of striatal projection neurons in parkinsonism and L-DOPA-induced dyskinesia
- (2014) Tim Fieblinger et al. Nature Communications
- L-dopa-induced dyskinesia: beyond an excessive dopamine tone in the striatum
- (2014) Gregory Porras et al. Scientific Reports
- Subcutaneous infusions of apomorphine: a reappraisal of its therapeutic efficacy in advanced Parkinson’s disease
- (2013) Francisco Grandas Expert Review of Neurotherapeutics
- Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study
- (2013) C Warren Olanow et al. LANCET NEUROLOGY
- Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson's disease
- (2013) C. Warren Olanow et al. MOVEMENT DISORDERS
- Study of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia
- (2013) Erwan Bezard et al. MOVEMENT DISORDERS
- Acute dopamine boost has a negative effect on plasticity of the primary motor cortex in advanced Parkinson's disease
- (2012) A. Kishore et al. BRAIN
- Treatment of motor and non-motor features of Parkinson's disease with deep brain stimulation
- (2012) Alfonso Fasano et al. LANCET NEUROLOGY
- Prefrontal thickening in PD with levodopa-induced dyskinesias: New evidence from cortical thickness measurement
- (2012) Antonio Cerasa et al. PARKINSONISM & RELATED DISORDERS
- Abnormal bidirectional plasticity-like effects in Parkinson's disease
- (2011) Y.-Z. Huang et al. BRAIN
- Glutamate NMDA receptor dysregulation in Parkinson’s disease with dyskinesias
- (2011) Imtiaz Ahmed et al. BRAIN
- Motor features and response to oral levodopa in patients with Parkinson’s disease under continuous dopaminergic infusion or deep brain stimulation
- (2011) A. E. Elia et al. EUROPEAN JOURNAL OF NEUROLOGY
- Catechol-O-methyltransferase Val158Met and the risk of dyskinesias in Parkinson's disease
- (2011) Lonneke M.L. de Lau et al. MOVEMENT DISORDERS
- Comparison of subthalamic nucleus deep brain stimulation and Duodopa in the treatment of advanced Parkinson's disease
- (2011) Aristide Merola et al. MOVEMENT DISORDERS
- Prefrontal alterations in Parkinson's disease with levodopa-induced dyskinesia during fMRI motor task
- (2011) Antonio Cerasa et al. MOVEMENT DISORDERS
- “Silly Walks” in Parkinson's disease: Unusual presentation of dopaminergic-induced dyskinesias
- (2011) Evžen Růžička et al. MOVEMENT DISORDERS
- The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease
- (2011) Susan H. Fox et al. MOVEMENT DISORDERS
- Regional changes in type 1 cannabinoid receptor availability in Parkinson's disease in vivo
- (2011) Koen Van Laere et al. NEUROBIOLOGY OF AGING
- Effects of noradrenergic denervation on L-DOPA-induced dyskinesia and its treatment by α- and β-adrenergic receptor antagonists in hemiparkinsonian rats
- (2011) Christopher J. Barnum et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Patient perception of dyskinesia in Parkinson's disease
- (2010) S. W. Hung et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Levetiracetam for the management of levodopa-induced dyskinesias in Parkinson's disease
- (2010) P. Stathis et al. MOVEMENT DISORDERS
- Differential genetic susceptibility in diphasic and peak-dose dyskinesias in Parkinson's disease
- (2010) Jee-Young Lee et al. MOVEMENT DISORDERS
- Management of Motor Complications in Parkinson Disease: Current and Emerging Therapies
- (2010) Alberto J. Espay NEUROLOGIC CLINICS
- Dyskinesia and the antiparkinsonian response always temporally coincide: A retrospective study
- (2010) J. G. Nutt et al. NEUROLOGY
- l-DOPA activates ERK signaling and phosphorylates histone H3 in the striatonigral medium spiny neurons of hemiparkinsonian mice
- (2008) Emanuela Santini et al. JOURNAL OF NEUROCHEMISTRY
- Reciprocal Regulation of Dopamine D1 and D3 Receptor Function and Trafficking by Heterodimerization
- (2008) C. Fiorentini et al. MOLECULAR PHARMACOLOGY
- Placebo influences on dyskinesia in Parkinson's disease
- (2008) Christopher G. Goetz et al. MOVEMENT DISORDERS
- Fourteen-year final report of the randomized PDRG-UK trial comparing three initial treatments in PD
- (2008) R. Katzenschlager et al. NEUROLOGY
- Priming for l-dopa-induced dyskinesia in Parkinson’s disease: A feature inherent to the treatment or the disease?
- (2008) Agnès Nadjar et al. PROGRESS IN NEUROBIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started